BR112018069100A2 - uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae - Google Patents

uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae

Info

Publication number
BR112018069100A2
BR112018069100A2 BR112018069100-3A BR112018069100A BR112018069100A2 BR 112018069100 A2 BR112018069100 A2 BR 112018069100A2 BR 112018069100 A BR112018069100 A BR 112018069100A BR 112018069100 A2 BR112018069100 A2 BR 112018069100A2
Authority
BR
Brazil
Prior art keywords
mycoplasma hyopneumoniae
virus infection
vaccine against
combined vaccine
pcv2 virus
Prior art date
Application number
BR112018069100-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Sno Melanie
Hendrik Witvliet Maarten
Fachinger Vicky
Original Assignee
Intervet International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International B.V. filed Critical Intervet International B.V.
Publication of BR112018069100A2 publication Critical patent/BR112018069100A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BR112018069100-3A 2016-03-23 2017-03-22 uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae BR112018069100A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16161997.8 2016-03-23
EP16161997 2016-03-23
PCT/EP2017/056831 WO2017162741A1 (en) 2016-03-23 2017-03-22 A combination vaccine against pcv2 virus and mycoplasma hyopneumoniae infection

Publications (1)

Publication Number Publication Date
BR112018069100A2 true BR112018069100A2 (pt) 2019-01-29

Family

ID=55589754

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018069100-3A BR112018069100A2 (pt) 2016-03-23 2017-03-22 uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae

Country Status (7)

Country Link
US (1) US20190105385A1 (cg-RX-API-DMAC10.html)
EP (1) EP3432919A1 (cg-RX-API-DMAC10.html)
JP (1) JP6907227B2 (cg-RX-API-DMAC10.html)
CN (1) CN108697782A (cg-RX-API-DMAC10.html)
BR (1) BR112018069100A2 (cg-RX-API-DMAC10.html)
RU (1) RU2018137034A (cg-RX-API-DMAC10.html)
WO (1) WO2017162741A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7354106B2 (ja) * 2017-12-04 2023-10-02 インターベット インターナショナル ベー． フェー． レプリコン粒子および油性アジュバントによるワクチン接種
CA3085535A1 (en) 2017-12-22 2019-06-27 Hipra Scientific, S.L.U. Intradermal combination vaccine against mycoplasma and porcine circovirus
CN114364398B (zh) * 2019-09-12 2025-08-22 英特维特国际股份有限公司 用于皮内施用的联合疫苗
EP4138892A1 (en) 2020-04-20 2023-03-01 Intervet International B.V. A vaccine to protect against mycoplasma hyopneumoniae
MX2022013080A (es) * 2020-04-20 2022-11-10 Intervet Int Bv Una combinacion de vacunas para el tratamiento profilactico de un cerdo.
CN115887636B (zh) * 2022-01-18 2026-07-03 武汉科前生物股份有限公司 猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法
AU2024402296A1 (en) 2023-12-19 2026-05-28 Intervet International B.V. Low-energy electron irradiation-inactivated mollicutes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014837A1 (en) * 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
PL1651265T3 (pl) * 2003-07-24 2008-10-31 Merial Ltd Formulacje szczepionek zawierających emulsję olej w wodzie
KR20110132416A (ko) * 2004-04-05 2011-12-07 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
CA2587321A1 (en) 2005-01-13 2006-07-20 Boehringer Ingelheim Vetmedica Gmbh Improved prrs vaccines
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
AR054822A1 (es) * 2005-07-07 2007-07-18 Sanofi Pasteur Emulsion inmuno adyuvante
CN101277717A (zh) 2005-09-09 2008-10-01 英特威国际有限公司 Pcv-2疫苗
CA2635430A1 (en) 2005-12-29 2007-08-23 Boehringer Ingelheim Vetmedica, Inc. Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
PT2094872T (pt) 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
US8728487B2 (en) 2011-01-20 2014-05-20 Hua Wu Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
EP2753354A4 (en) * 2011-09-09 2015-04-15 Nanobio Corp SUB-VACCINE IN NANOEMULSION FORM FOR RESPIRATORY SYNZYTIAL VIRUS
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9457073B2 (en) 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
CN104043118A (zh) * 2013-03-11 2014-09-17 普莱柯生物工程股份有限公司 猪prrsv、猪肺炎支原体和pvc-2抗原在制备疫苗中的应用
CN103263666B (zh) * 2013-05-24 2019-07-16 北京大北农科技集团股份有限公司动物医学研究中心 猪圆环病毒2型、猪支原体肺炎二联灭活疫苗及其制备方法
WO2015082457A1 (en) * 2013-12-03 2015-06-11 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2

Also Published As

Publication number Publication date
US20190105385A1 (en) 2019-04-11
RU2018137034A3 (cg-RX-API-DMAC10.html) 2020-06-26
JP2019509300A (ja) 2019-04-04
CN108697782A (zh) 2018-10-23
RU2018137034A (ru) 2020-04-23
EP3432919A1 (en) 2019-01-30
WO2017162741A1 (en) 2017-09-28
JP6907227B2 (ja) 2021-07-21

Similar Documents

Publication Publication Date Title
MX2018014573A (es) Vacuna contra el virus del zika.
AR090614A1 (es) Vacuna de combinacion contra pcv / mycoplasma hyopneumoniae / srrp
CO7160025A2 (es) Vacuna de combinación contra pcv/mycoplasma hyopneumoniae
CR20140436A (es) Vacuna de combinación contra mycoplasma hyopneumoniae
MX2009008577A (es) Prevencion y tratamiento contra la enfermedad asociada a arcovirus porcion sub-clinica.
MX395525B (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
MX2019008564A (es) Composiciones inmunogenicas para su uso en vacunas neumococicas.
CL2019003805A1 (es) Composiciones inmunógenas de senecavirus a y métodos de éstas.
CO6270337A2 (es) Vacuna viva avirulenta de mycoplama hyopneumoniae con adyuvante
MX369474B (es) Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad.
UY32208A (es) Uso de antigeno de mycoplasma bovis
MX2019007349A (es) Vacuna combinada para cerdos.
PE20151588A1 (es) Vacuna contra el virus del dengue
BR112018075440A2 (pt) composições e métodos para prevenir e tratar a infecção por zika vírus
CL2021002582A1 (es) Vacunas contra el circovirus porcino tipo 3 (pcv3), su producción y usos
BR112017000519A2 (pt) "composição imunogênica, e, método para proteger um mamífero contra uma infecção meningocócica"
MX2017009306A (es) Vacuna contra la fiebre aftosa.
BR112022004256A2 (pt) Vacina de combinação para administração intradérmica
BR112016012435A8 (pt) vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
MX2020006662A (es) Vacuna combinada intradermica contra mycoplasma y circovirus porcino.
BR112015031226A2 (pt) Composição de vacina, e, uso da composição de vacina
JP2019509300A5 (cg-RX-API-DMAC10.html)
MX2018007950A (es) Vacuna multivalente m hyo y usos de la misma.
BR112016012393A2 (pt) Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado
BR112022019207A2 (pt) Composições de vacina para coronavírus e métodos de uso das mesmas

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]